The decrease in glutamine was of particular interest, as pharmacological blockade of glutamine metabolism in tumour-bearing mice or glutaminase deletion in tumour cells suppresses cancer cell growth and enhances CD8+ T cell anti-tumour activity21,22. The gene discussed is CD8A; the disease is cancer.